|
Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care Clinical research trials and Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care. Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care clinical trial. Participants frequently obtain the most expert healthcare available for their Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care  Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
For Condition: Quality of Life,unspecified adult solid tumor, protocol specific
Status: Recruiting
Sponsor(s): EORTC Quality of Life Study Group ,
Synopsis: RATIONALE: Questionnaires may help determine cancer patients' satisfaction with the quality of care they received in the hospital. PURPOSE: Clinical trial to determine the effectiveness of questionnaires in assessing cancer patients' satisfaction with the quality of care they received in the hospital.
Details: OBJECTIVES: - Determine the scale structure, reliability, and validity of the QLQ-SAT32 patient satisfaction module in assessing the perception of the quality of care received in hospitals by patients with cancer. - Determine the success of the QLQ-SAT32 patient satisfaction module when used with the QLQ-C30 core quality of life questionnaire, in terms of expanding on quality of life evaluation or providing information on treatment acceptability or preference of these patients. OUTLINE: This is a descriptive, multicenter study. Patients are stratified according to age (18 to 49 vs 50 and over) and the cancer therapy received in hospital (surgery vs chemotherapy). Patients in all strata receive the QLQ-SAT32 and QLQ-C30 questionnaires, a debriefing questionnaire, and the Oberst patient satisfaction visual analog scale prior to hospital discharge. Patients complete the materials at home within 7 days of discharge. A group of 100 patients have a repeat QLQ-SAT32 module mailed to them to be completed within 7 days of receipt of first questionnaire. PROJECTED ACCRUAL: A total of 640-768 patients (160-192 per stratum) will be accrued for this study.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Histologically confirmed cancer - Hospitalization of at least 3 days - No clinical evidence of brain metastases PATIENT CHARACTERISTICS: Age - 18 and over Performance status - Not specified Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified Other - No psychological, familial, sociological, or geographical condition that would preclude study - Able to understand the language of the questionnaire - Mentally fit to complete a questionnaire PRIOR CONCURRENT THERAPY: Biologic therapy - Not specified Chemotherapy - Prior chemotherapy allowed Endocrine therapy - Not specified Radiotherapy - Not specified Surgery - Prior surgery for cancer allowed Other - No concurrent participation in other quality of life studies that would preclude this study
Total Enrollment:
Location and Contact Information:
Overall Study Official:
AnneBredart, , Institut Curie - Section Medicale
Sahlgrenska University Hospital *Recruiting*
GOTHENBURG, , S-413 45
Sweden
Recruiting Contact Person 46-31-60-1000
Centre Alexis Vautrin *Recruiting*
Vandoeuvre-les-Nancy, , 54511
France
Recruiting Contact Person 33-3-8359-8400
Centre Paul Strauss *Recruiting*
Strasbourg, , 67085
France
Recruiting Contact Person 33-388-252-424
Institut Gustave Roussy *Recruiting*
Villejuif, , F-94805
France
Recruiting Contact Person 33-1-4211-4211
Hospital De Navarra *Recruiting*
Pamplona, , 31008
Spain
Recruiting Contact Person 34-102261
Uppsala University Hospital *Recruiting*
Uppsala, , S-75183
Sweden
Recruiting Contact Person 46-18-611-3402
Institut Bergonie *Recruiting*
Bordeaux, , 33076
France
Recruiting Contact Person 33-556-333-333
Centre Regional Francois Baclesse *Recruiting*
Caen, , 14076
France
Recruiting Contact Person 33-2-3145-5000
Institut Curie - Section Medicale *Recruiting*
Paris, , 75231
France
Recruiting Contact Person 33-1-4432-4000
Bristol Royal Infirmary *Recruiting*
Bristol, , BS2 8HW
United Kingdom
Recruiting Contact Person 44-117-923-0000
Institut Jules Bordet *Recruiting*
Brussels, , 1000
Belgium
Recruiting Contact Person 32-2-541-3111
Additional Information:
Study ID Numbers: CDR0000256317; EORTC-15012
Study Start Date:
Record last reviewed: October 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00045019
Other Quality Of Life Studies:
1. Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
2. Combination Chemotherapy In Treating Patients With Advanced Cancer
3. Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
4. Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
5. Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
Related Studies:
Other Quality of Life Clinical Trials
Other Clinical Trials
Other GOTHENBURG Clinical Trials
Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
|
|
|
|
|
|
|
|
